Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis

ConclusionsCompared with other new intranasal-specific therapies in treating migraine attacks, zolmitriptan nasal spray 5  mg was the most effective agent for pain freedom at 2 h. Zavegepant nasal spray 10 mg had the fewest adverse side effects.

Source: The Journal of Headache and Pain - September 18, 2023 Category: Neurology Source Type: research